Good afternoon :)
Place Order
Add to Watchlist

Zenith Drugs Ltd

ZENITHDRUG Share Price

59.301.50% (-0.90)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹101 cr, stock is ranked 3,156

Stock is 5.04x as volatile as Nifty

ZENITHDRUG Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹101 cr, stock is ranked 3,156

Stock is 5.04x as volatile as Nifty

ZENITHDRUG Performance & Key Metrics

ZENITHDRUG Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
1.47
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
37.155.870.59%

ZENITHDRUG Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

ZENITHDRUG Company Profile

Zenith Drugs is an India-based pharmaceutical manufacturing and trading company.

ZENITHDRUG Similar Stocks (Peers)

Compare with peers Compare with peers 

ZENITHDRUG Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
38.57
38.57
1Y Return
0.63%
0.63%
Buy Reco %
91.43
91.43
PE Ratio
67.85
67.85
1Y Return
23.51%
23.51%
Buy Reco %
76.92
76.92
PE Ratio
23.47
23.47
1Y Return
2.16%
2.16%
Buy Reco %
67.74
67.74
PE Ratio
18.34
18.34
1Y Return
1.57%
1.57%
Buy Reco %
41.94
41.94
PE Ratio
21.00
21.00
1Y Return
1.35%
1.35%
Buy Reco %
50.00
50.00
Compare with Peers

ZENITHDRUG Forecast

ZENITHDRUG Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

ZENITHDRUG

ZENITHDRUG

Income

Balance Sheet

Cash Flow

ZENITHDRUG Income Statement

ZENITHDRUG Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 11.65%, vs industry avg of 10.03%

Constant Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share stayed at 0.03%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 16.06%, vs industry avg of 20.02%

Loading...

Financial YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue78.3373.5192.60115.76133.74135.93
Raw Materialssubtract53.6447.6969.190.0036.4152.76
Power & Fuel Costsubtract0.030.000.001.041.091.59
Employee Costsubtract3.002.412.984.965.346.76
Selling & Administrative Expensessubtract9.8410.959.130.0015.6214.84
Operating & Other expensessubtract4.725.163.4399.4757.6944.04
Depreciation/Amortizationsubtract0.921.221.341.301.302.97
Interest & Other Itemssubtract1.311.492.142.333.003.71
Taxes & Other Itemssubtract1.471.531.191.783.752.10
EPS85.0076.5080.00122.0010.874.18
DPS0.000.000.000.000.500.00
Payout ratio0.000.000.000.000.050.00

ZENITHDRUG Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
 

ZENITHDRUG Stock Peers

ZENITHDRUG Past Performance & Peer Comparison

ZENITHDRUG Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Zenith Drugs Ltd14.201.47
Sun Pharmaceutical Industries Ltd38.575.820.91%
Torrent Pharmaceuticals Ltd67.8517.080.84%
Cipla Ltd23.473.961.04%

ZENITHDRUG Stock Price Comparison

Compare ZENITHDRUG with any stock or ETF
Compare ZENITHDRUG with any stock or ETF
ZENITHDRUG
Loading...

ZENITHDRUG Holdings

ZENITHDRUG Shareholdings

ZENITHDRUG Promoter Holdings Trend

ZENITHDRUG Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

ZENITHDRUG Institutional Holdings Trend

ZENITHDRUG Institutional Holdings Trend

No institutional holdings trend are available

Tickertape Separator

ZENITHDRUG Shareholding Pattern

ZENITHDRUG Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding69.98%0.00%0.00%0.00%30.02%

Mar 2024

Sep 2024

Mar 2025

Sep 2025

ZENITHDRUG Shareholding History

ZENITHDRUG Shareholding History

SepFebMarSepMarSep0.00%7.40%5.81%0.42%0.06%0.00%

ZENITHDRUG Insider Trades & Bulk Stock Deals

ZENITHDRUG Insider Trades & Bulk Stock Deals

Loading...

smallcases containing ZENITHDRUG stock

smallcases containing ZENITHDRUG stock

Looks like this stock is not in any smallcase yet.

ZENITHDRUG Events

ZENITHDRUG Events

ZENITHDRUG Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

ZENITHDRUG Dividend Trend

No dividend trend available

ZENITHDRUG Upcoming Dividends

ZENITHDRUG Upcoming Dividends

No upcoming dividends are available

ZENITHDRUG Past Dividends

ZENITHDRUG Past Dividends

Cash Dividend

Ex DateEx DateSep 17, 2024

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Sep 17, 2024

ZENITHDRUG Stock News & Opinions

ZENITHDRUG Stock News & Opinions

Corporate
Zenith Drugs to convene board meeting

Zenith Drugs will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live

5 days agoCapital Market - Live
Corporate
Zenith Drugs schedules AGM

Zenith Drugs announced that the 25th Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Zenith Drugs to hold board meeting

Zenith Drugs will hold a meeting of the Board of Directors of the Company on 29 May 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Zenith Drugs to hold board meeting

Zenith Drugs will hold a meeting of the Board of Directors of the Company on 12 April 2025.Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Zenith Drugs to table results

Zenith Drugs will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

1 year agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Zenith Drugs Ltd (ZENITHDRUG) today?

    The share price of ZENITHDRUG as on 14th November 2025 is ₹59.30. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Zenith Drugs Ltd (ZENITHDRUG) share?

    The past returns of Zenith Drugs Ltd (ZENITHDRUG) share are
    • Past 1 week: -0.85%
    • Past 1 month: -9.30%
    • Past 3 months: -7.78%
    • Past 6 months: -25.41%
    • Past 1 year: -40.13%
    • Past 3 years: N/A%
    • Past 5 years: -43.60%

  3. What are the peers or stocks similar to Zenith Drugs Ltd (ZENITHDRUG)?
  4. What is the market cap of Zenith Drugs Ltd (ZENITHDRUG) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Zenith Drugs Ltd (ZENITHDRUG) is ₹101.69 Cr as of 14th November 2025.

  5. What is the 52 week high and low of Zenith Drugs Ltd (ZENITHDRUG) share?

    The 52-week high of Zenith Drugs Ltd (ZENITHDRUG) is ₹107 and the 52-week low is ₹47.15.

  6. What is the PE and PB ratio of Zenith Drugs Ltd (ZENITHDRUG) stock?

    The P/E (price-to-earnings) ratio of Zenith Drugs Ltd (ZENITHDRUG) is 14.20. The P/B (price-to-book) ratio is 1.47.

  7. Which sector does Zenith Drugs Ltd (ZENITHDRUG) belong to?

    Zenith Drugs Ltd (ZENITHDRUG) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Zenith Drugs Ltd (ZENITHDRUG) shares?

    You can directly buy Zenith Drugs Ltd (ZENITHDRUG) shares on Tickertape. Simply sign up, connect your demat account and place your order.